|4Jun 28, 4:10 PM ET

Keefer Jason 4

4 · OSIRIS THERAPEUTICS, INC. · Filed Jun 28, 2018

Insider Transaction Report

Form 4
Period: 2018-06-26
Keefer Jason
Interim President & CEO
Transactions
  • Award

    Incentive Stock Option (right to buy)

    2018-06-26+20,00036,000 total
    Exercise: $10.53From: 2019-06-26Exp: 2028-06-26Common Stock (20,000 underlying)
Footnotes (1)
  • [F1]25% of the shares underlying this option shall vest on each of June 26, 2019, June 26, 2020, June 26, 2021 and June 26, 2022, subject to Reporting Person's continued service through the applicable vesting date.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT